Joseph Konowiecki, Chairman and EVP of Corporate Affairs at Alignment Healthcare, Inc., filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 5,500 shares of common stock with an approximate sale date of November 10, 2026.

Key Highlights

  • Proposed seller: Joseph Konowiecki, identified in the filing as Chairman and EVP, Corporate Affairs of Alignment Healthcare, Inc.
  • Shares proposed for sale: 5,500 shares of common stock, with an aggregate market value of $39,985 as stated in the filing.
  • Shares outstanding: The filing reports 209,268,394 shares of common stock outstanding.
  • Acquisition origin: The shares were acquired through the vesting of restricted stock units granted on November 7, 2022, under the issuer's 2021 Equity Incentive Plan; 13,476 units were acquired on that date.
  • Prior sales: Konowiecki sold 23,511 shares on September 17, 2026, with gross proceeds of $202,429.71, according to the filing's three-month sales history.
  • Nature of transaction: The filing states the shares are to be sold "pursuant to a sale-to-cover transaction and does not represent a discretionary trade by the reporting person."
  • Exchange and broker: The proposed sale is to be executed on the Nasdaq Stock Market through E-Trade Finance, Arlington, VA.

Konowiecki's Proposed Sale Details at Alignment Healthcare

According to the Form 144 notice filed with the U.S. Securities and Exchange Commission on November 9, 2026, Joseph Konowiecki, the Chairman and EVP of Corporate Affairs at Alignment Healthcare, Inc. (NASDAQ:ALHC), disclosed a proposed sale of 5,500 shares of the company's common stock. The filing identifies the broker as E-Trade Finance, with an approximate sale date of November 10, 2026, and an aggregate market value of $39,985 for the shares to be sold.

The filing discloses that the shares to be sold were acquired through the vesting of restricted stock units originally granted on November 7, 2022, under Alignment Healthcare's 2021 Equity Incentive Plan. The filing records 13,476 units as having been acquired on that date. The form also notes that payment was recorded as "n/a," consistent with an RSU vesting transaction rather than an open-market purchase.

In the remarks section, the filing states that the proposed sale is "pursuant to a sale-to-cover transaction and does not represent a discretionary trade by the reporting person," and further notes that the "actual number of shares sold will be determined based on applicable tax withholding rates and stock price at the time of sale." The filing also discloses that Konowiecki sold 23,511 shares on September 17, 2026, generating gross proceeds of $202,429.71, within the three months preceding this notice. As of the filing, total common shares outstanding are reported as 209,268,394.

What Was Disclosed

Alignment Healthcare's Chairman and EVP, Joseph Konowiecki, filed a Form 144 notice on November 9, 2026, proposing to sell 5,500 common shares acquired via RSU vesting, valued at $39,985, in a sale-to-cover transaction on the Nasdaq Stock Market on or around November 10, 2026.